Fannin Innovation Studio
Houston, Texasfannininnovation.com
Overview
Fannin Partners, operating as Fannin Innovation Studio, is a venture capital firm based in Houston, Texas, that invests in early-stage therapeutic, medical device, and diagnostic technologies sourced from leading academic investigators across the United States. The firm focuses on commercializing medical technologies by in-licensing assets or technologies from academic institutions and developing them internally through clinical proof of concept. Fannin also grows life sciences product developers locally through its apprenticeship programs.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Goldenrod Therapeutics, Inc. | Jun 2026 | Seed | Lead |
| Pulmotect | Sep 2024 | Series C | Lead |
| Procyrion | Feb 2024 | Series E | Lead |
| Procyrion | Jul 2019 | Series D | Co-investor |
| Pulmotect | Apr 2018 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.